Contact: Joshua Weissman, Director of Patient Services, jweissman@friendsforlife.com

Magic pill for CML patients wins marketing approval

GAINESVILLE, May 5, 2001 — Friends for Life of America is pleased to provide information on Gleevec, a new drug recently approved by the U.S. Food and Drug Administration for the treatment of chronic myelogenous leukemia (CML) in patients who have failed standard therapy.

In an effort to inform communities with Friends for Life of America chapters about this exciting new development, the Office of Patient Services is distributing informational pamphlets about Gleevec.

For detailed information about Gleevec from CNN, please visit http://www.cnn.com/2001/HEALTH/conditions/05/10/cancer.pill.approved/index.html.

About Friends for Life of America
Friends for Life of America is a national student organization that helps improve the quality of life for pediatric leukemia patients and their families by offering unique programs and services.